Clinical Trials
40 trialsA Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)
Ontario Clinical Oncology Group (OCOG)
Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer
Borstkanker Onderzoek Groep
BreathBC
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
A Novel Approach in the Evaluation of Breast Masses With Doppler US
Karamanoğlu Mehmetbey University
Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response
University of Wisconsin, Madison
ATRA
Mario Negri Institute for Pharmacological Research
Piloting 18F-FAPI PET/MRI for Applications in Breast Cancer
St. Olavs Hospital
SBRT in Early Breast Cancer in Elderly Women
University of Rome Tor Vergata
Investigating the Effects of Different Incision Types on Aesthetic Outcomes and Incision-related Complications After Breast Reconstruction Surgery
Hubei Cancer Hospital
PALVEN
Peter MacCallum Cancer Centre, Australia
Efficacy of Preparation in Self-Hypnosis by Anchoring Versus Conversational Hypnosis, Used Alone or Combined, in Patients Undergoing Breast Macrobiopsies
Hospital St. Joseph, Marseille, France
Phi-Bra
Hospices Civils de Lyon
SEINPOL
Centre Hospitalier Universitaire de Nice
PRO
Regina Elena Cancer Institute
neoPICD
First Affiliated Hospital of Wenzhou Medical University
GEFPICS IHC4
UNICANCER
Diagnostic Biomarkers Exploration of Breast Cancer From Serum and Urine
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
THRIVE
Emory University
Palbociclib Combine With Anti-HER2 Therapy in Triple Positive ABC
Peking University Cancer Hospital & Institute
RFID
Centre Jean Perrin
BRCA-DIRECT
Institute of Cancer Research, United Kingdom
Mayo Designed Soft Tissue Ultrasound-Detectable Marker
Mayo Clinic
AvBSR
Second Affiliated Hospital, School of Medicine, Zhejiang University
Diagnosis Value of SEMA4C in Breast Cancer
Tongji Hospital
Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy for HR +/HER2 + Advanced Breast Cancer
Peking University Cancer Hospital & Institute
AK105 Plus Anlotinib Hydrochloride Combined With Albumin Paclitaxel as a First-line Therapy in Patients With Advanced Triple-negative Breast Cancer
Liaoning Cancer Hospital & Institute
Effectiveness and Safety of Fulvestrant in Postmenopausal Women With Advanced Breast Cancer HR+, HER2-
Dr. Reddy's Laboratories SAS
The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer
Zhejiang Cancer Hospital
TARGIT-X
University College, London
HaemoCerTM Application in Breast Cancer Surgery
Medical University of Vienna
Retrospective Comparative in Vitro Case-controlled Study of the Liquid Biopsy Test System in Women With Breast Cancer
ARNA Genomics US Inc.
PECS-2 for Breast Surgery
Umeå University
SYSBTC-001
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Breast PET
University College, London
ePainQ
The Leeds Teaching Hospitals NHS Trust
AETAPP
University of Tennessee
The Effect of Yoga on Barriers to Occupational Engagement in African American Breast Cancer Survivors
Mount Mary University
iNPWT in Immediate Breast Reconstruction
University of Aarhus
WE
Dalarna County Council, Sweden
NACVCAC
The First Hospital of Jilin University